Corporate Sustainability
► Strengthening Sustainability Governance and Supply Chain Management:
To advance its sustainability policies and initiatives, Greenyn Biotechnology has established a Sustainability Management Committee under the Board of Directors as a key governance mechanism for sustainable development. The Company has also designated a part-time sustainability unit and established five working groups focusing on Employee Care, Social Engagement, Environmental Sustainability, Corporate Governance, and Product Responsibility. Relevant departments work collaboratively to implement sustainability initiatives within their respective areas of responsibility.
To strengthen greenhouse gas (GHG) information management and facilitate the transfer of GHG inventory experience, the Company has established a GHG Inventory Task Force to coordinate inventory activities and related information management across departments. In 2023, Greenyn Biotechnology officially became a supporter of the Task Force on Climate-related Financial Disclosures (TCFD), further strengthening its identification and management of climate-related risks and opportunities.
In 2024, the Company conducted a sustainability materiality assessment from a double materiality perspective and referenced IFRS S1, General Requirements for Disclosure of Sustainability-related Financial Information, and IFRS S2, Climate-related Disclosures, to further assess the links between sustainability matters and their potential impacts on business operations. The assessment results are disclosed in the Company’s annual Sustainability Report.
In supply chain management, Greenyn Biotechnology continues to assess supplier performance and conduct sustainability questionnaires among key suppliers to better understand their operational and sustainability management practices. In 2025, the Company had 274 qualified suppliers and distributed sustainability questionnaires to 25 key suppliers, receiving 13 responses, representing a 52% response rate. The Company also continues to review and consolidate its supplier base based on actual business relationships, procurement needs, and supplier quality performance, with the aim of strengthening supply chain management and resilience.

We invite you to share your thoughts on key ESG topics through this short anonymous survey.
Your feedback will help Greenyn Biotechnology strengthen stakeholder communication and enhance our sustainability efforts.
Survey link: https://forms.gle/t66M1JtppanHzkZ3A
To advance its sustainability policies and initiatives, Greenyn Biotechnology has established a Sustainability Management Committee under the Board of Directors as a key governance mechanism for sustainable development. The Company has also designated a part-time sustainability unit and established five working groups focusing on Employee Care, Social Engagement, Environmental Sustainability, Corporate Governance, and Product Responsibility. Relevant departments work collaboratively to implement sustainability initiatives within their respective areas of responsibility.
To strengthen greenhouse gas (GHG) information management and facilitate the transfer of GHG inventory experience, the Company has established a GHG Inventory Task Force to coordinate inventory activities and related information management across departments. In 2023, Greenyn Biotechnology officially became a supporter of the Task Force on Climate-related Financial Disclosures (TCFD), further strengthening its identification and management of climate-related risks and opportunities.
In 2024, the Company conducted a sustainability materiality assessment from a double materiality perspective and referenced IFRS S1, General Requirements for Disclosure of Sustainability-related Financial Information, and IFRS S2, Climate-related Disclosures, to further assess the links between sustainability matters and their potential impacts on business operations. The assessment results are disclosed in the Company’s annual Sustainability Report.
In supply chain management, Greenyn Biotechnology continues to assess supplier performance and conduct sustainability questionnaires among key suppliers to better understand their operational and sustainability management practices. In 2025, the Company had 274 qualified suppliers and distributed sustainability questionnaires to 25 key suppliers, receiving 13 responses, representing a 52% response rate. The Company also continues to review and consolidate its supplier base based on actual business relationships, procurement needs, and supplier quality performance, with the aim of strengthening supply chain management and resilience.


We invite you to share your thoughts on key ESG topics through this short anonymous survey.
Your feedback will help Greenyn Biotechnology strengthen stakeholder communication and enhance our sustainability efforts.
Survey link: https://forms.gle/t66M1JtppanHzkZ3A
Links
LINKSGREEN biotechnology





